Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials

Endocrinol Diabetes Metab. 2026 Sep;9(5):e70313. doi: 10.1002/edm2.70313.ABSTRACTBACKGROUND AND AIM: This network meta-analysis addresses the limited dose-specific comparative evidence by evaluating different doses of tirzepatide (TZP) versus dulaglutide (DULA) for glycemic control, weight loss, and

A Ahmed W Hageen

Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model

Cardiovasc Diabetol. 2026 Aug 5;25(1):270. doi: 10.1186/s12933-026-03281-2.ABSTRACTBACKGROUND: Hypertension is closely related to the development and mortality of cardiovascular disease (CVD), insulin resistance (IR) plays a key role in hypertension-related metabolic dysfunction, but there is no uni

Y Yuting Zhang